Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,017
archived clinical trials in
Angina

"SVEAT" Chest Pain Scoring System
Performance of a New Risk Score (SVEAT Index) to Identify Low-risk Patients Presenting to Emergency Department With Acute Chest Pain
Status: Enrolling
Updated:  12/31/1969
Renown Regional Medical Center
mi
from
Reno, NV
"SVEAT" Chest Pain Scoring System
Performance of a New Risk Score (SVEAT Index) to Identify Low-risk Patients Presenting to Emergency Department With Acute Chest Pain
Status: Enrolling
Updated: 12/31/1969
Renown Regional Medical Center
mi
from
Reno, NV
Click here to add this to my saved trials
Efficacy of Ranolazine in Patients With Chronic Total Occlusions of Coronary Arteries
The Effectiveness of Ranolazine in Reducing Cardiac Ischaemia Induced by Chronic Total Occlusions of Coronary Arteries
Status: Enrolling
Updated:  12/31/1969
East Carolina Heart Institute at Vidant Medical Center
mi
from
Greenville, NC
Efficacy of Ranolazine in Patients With Chronic Total Occlusions of Coronary Arteries
The Effectiveness of Ranolazine in Reducing Cardiac Ischaemia Induced by Chronic Total Occlusions of Coronary Arteries
Status: Enrolling
Updated: 12/31/1969
East Carolina Heart Institute at Vidant Medical Center
mi
from
Greenville, NC
Click here to add this to my saved trials
MyoStrain CMR Testing of Ischemia With Low Levels of Stress
MyoStrain CMR Testing of Ischemia With Low Levels of Stress
Status: Enrolling
Updated:  12/31/1969
WakeMed
mi
from
Raleigh, NC
MyoStrain CMR Testing of Ischemia With Low Levels of Stress
MyoStrain CMR Testing of Ischemia With Low Levels of Stress
Status: Enrolling
Updated: 12/31/1969
WakeMed
mi
from
Raleigh, NC
Click here to add this to my saved trials
Magnetocardiography Using a Novel Analysis System (Cardioflux) in the Evaluation of Emergency Department Observation Unit Chest Pain Patients
Magnetocardiography Using a Novel Analysis System (Cardioflux) in the Evaluation of Emergency Department Observation Unit Chest Pain Patients
Status: Enrolling
Updated:  12/31/1969
St John Hospital & Medical Center
mi
from
Detroit, MI
Magnetocardiography Using a Novel Analysis System (Cardioflux) in the Evaluation of Emergency Department Observation Unit Chest Pain Patients
Magnetocardiography Using a Novel Analysis System (Cardioflux) in the Evaluation of Emergency Department Observation Unit Chest Pain Patients
Status: Enrolling
Updated: 12/31/1969
St John Hospital & Medical Center
mi
from
Detroit, MI
Click here to add this to my saved trials
Investigation of Cannabinoid Receptor Agonist Dronabinol in Patients With Functional Chest Pain
Investigation of Cannabinoid Receptor Agonist Dronabinol in Patients With Functional Chest Pain
Status: Enrolling
Updated:  12/31/1969
Temple University Hospital
mi
from
Philadelphia, PA
Investigation of Cannabinoid Receptor Agonist Dronabinol in Patients With Functional Chest Pain
Investigation of Cannabinoid Receptor Agonist Dronabinol in Patients With Functional Chest Pain
Status: Enrolling
Updated: 12/31/1969
Temple University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Developing Enhanced Prediction Models
Developing Enhanced Prediction Models to Identify Patients at Risk for Hospital Readmission by Collecting Patient-Generated Health Data
Status: Enrolling
Updated:  12/31/1969
Penn Medicine
mi
from
Philadelphia, PA
Developing Enhanced Prediction Models
Developing Enhanced Prediction Models to Identify Patients at Risk for Hospital Readmission by Collecting Patient-Generated Health Data
Status: Enrolling
Updated: 12/31/1969
Penn Medicine
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Role of Esophageal Mast Cell Activation in Noncardiac Chest Pain (NCCP)
Role of Esophageal Mast Cell Activation in Noncardiac Chest Pain (NCCP)
Status: Enrolling
Updated:  9/16/2005
Penn State College of Medicine Hershey Medical Center
mi
from
Hershey, PA
Role of Esophageal Mast Cell Activation in Noncardiac Chest Pain (NCCP)
Role of Esophageal Mast Cell Activation in Noncardiac Chest Pain (NCCP)
Status: Enrolling
Updated: 9/16/2005
Penn State College of Medicine Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Role of Plavix in Hemorrhagic and Ischemic Complications of Catheterization.
Impact of Pre-Treatment With 600mg of Clopidogrel (Plavix) on the Incidence of Ischemic and Hemorrhagic Complications in Patients Undergoing Elective Percutaneous Coronary Revascularization.--Prospective Randomized Trial.
Status: Enrolling
Updated:  3/10/2008
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Role of Plavix in Hemorrhagic and Ischemic Complications of Catheterization.
Impact of Pre-Treatment With 600mg of Clopidogrel (Plavix) on the Incidence of Ischemic and Hemorrhagic Complications in Patients Undergoing Elective Percutaneous Coronary Revascularization.--Prospective Randomized Trial.
Status: Enrolling
Updated: 3/10/2008
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Beta-Blocker Before Extubation
Use of Prophylactic Beta Blockade to Prevent Peri-Extubation Cardiac Ischemia and Congestive Heart Failure
Status: Enrolling
Updated:  7/22/2008
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Beta-Blocker Before Extubation
Use of Prophylactic Beta Blockade to Prevent Peri-Extubation Cardiac Ischemia and Congestive Heart Failure
Status: Enrolling
Updated: 7/22/2008
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
Serp-1 for the Treatment of Acute Coronary Syndrome
A Phase 2, Multicentre, Double-Blind, Placebo-Controlled, Dose Escalating Trial of the Safety, Pharmacokinetics, and Biological Activity of 3 Consecutive Daily Doses of Serp-1 When Added to Conventional Therapy in Patients With Acute Coronary Syndromes (Non ST-Elevation Myocardial Infarction and/or Unstable Angina)
Status: Enrolling
Updated:  2/5/2009
MedStar Washington Hospital Center
mi
from
Washington,
Serp-1 for the Treatment of Acute Coronary Syndrome
A Phase 2, Multicentre, Double-Blind, Placebo-Controlled, Dose Escalating Trial of the Safety, Pharmacokinetics, and Biological Activity of 3 Consecutive Daily Doses of Serp-1 When Added to Conventional Therapy in Patients With Acute Coronary Syndromes (Non ST-Elevation Myocardial Infarction and/or Unstable Angina)
Status: Enrolling
Updated: 2/5/2009
MedStar Washington Hospital Center
mi
from
Washington,
Click here to add this to my saved trials
Serp-1 for the Treatment of Acute Coronary Syndrome
A Phase 2, Multicentre, Double-Blind, Placebo-Controlled, Dose Escalating Trial of the Safety, Pharmacokinetics, and Biological Activity of 3 Consecutive Daily Doses of Serp-1 When Added to Conventional Therapy in Patients With Acute Coronary Syndromes (Non ST-Elevation Myocardial Infarction and/or Unstable Angina)
Status: Enrolling
Updated:  2/5/2009
University of Florida
mi
from
Gainesville, FL
Serp-1 for the Treatment of Acute Coronary Syndrome
A Phase 2, Multicentre, Double-Blind, Placebo-Controlled, Dose Escalating Trial of the Safety, Pharmacokinetics, and Biological Activity of 3 Consecutive Daily Doses of Serp-1 When Added to Conventional Therapy in Patients With Acute Coronary Syndromes (Non ST-Elevation Myocardial Infarction and/or Unstable Angina)
Status: Enrolling
Updated: 2/5/2009
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Serp-1 for the Treatment of Acute Coronary Syndrome
A Phase 2, Multicentre, Double-Blind, Placebo-Controlled, Dose Escalating Trial of the Safety, Pharmacokinetics, and Biological Activity of 3 Consecutive Daily Doses of Serp-1 When Added to Conventional Therapy in Patients With Acute Coronary Syndromes (Non ST-Elevation Myocardial Infarction and/or Unstable Angina)
Status: Enrolling
Updated:  2/5/2009
Spectrum Health
mi
from
Grand Rapids, MI
Serp-1 for the Treatment of Acute Coronary Syndrome
A Phase 2, Multicentre, Double-Blind, Placebo-Controlled, Dose Escalating Trial of the Safety, Pharmacokinetics, and Biological Activity of 3 Consecutive Daily Doses of Serp-1 When Added to Conventional Therapy in Patients With Acute Coronary Syndromes (Non ST-Elevation Myocardial Infarction and/or Unstable Angina)
Status: Enrolling
Updated: 2/5/2009
Spectrum Health
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Serp-1 for the Treatment of Acute Coronary Syndrome
A Phase 2, Multicentre, Double-Blind, Placebo-Controlled, Dose Escalating Trial of the Safety, Pharmacokinetics, and Biological Activity of 3 Consecutive Daily Doses of Serp-1 When Added to Conventional Therapy in Patients With Acute Coronary Syndromes (Non ST-Elevation Myocardial Infarction and/or Unstable Angina)
Status: Enrolling
Updated:  2/5/2009
Victoria Heart Institute
mi
from
Vicotria,
Serp-1 for the Treatment of Acute Coronary Syndrome
A Phase 2, Multicentre, Double-Blind, Placebo-Controlled, Dose Escalating Trial of the Safety, Pharmacokinetics, and Biological Activity of 3 Consecutive Daily Doses of Serp-1 When Added to Conventional Therapy in Patients With Acute Coronary Syndromes (Non ST-Elevation Myocardial Infarction and/or Unstable Angina)
Status: Enrolling
Updated: 2/5/2009
Victoria Heart Institute
mi
from
Vicotria,
Click here to add this to my saved trials
The Comparison of the Necessity of Repeat Myocardial Perfusion SPECT Studies Between Tc-99m Tetro and Tc-99m Mibi
The Comparison of the Necessity of Repeat Myocardial Perfusion SPECT Studies Between Tc-99m Tetrofosmin and Tc-99m Sestamibi
Status: Enrolling
Updated:  1/11/2010
Cardiac Imaging of Augusta
mi
from
Augusta, GA
The Comparison of the Necessity of Repeat Myocardial Perfusion SPECT Studies Between Tc-99m Tetro and Tc-99m Mibi
The Comparison of the Necessity of Repeat Myocardial Perfusion SPECT Studies Between Tc-99m Tetrofosmin and Tc-99m Sestamibi
Status: Enrolling
Updated: 1/11/2010
Cardiac Imaging of Augusta
mi
from
Augusta, GA
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
Cardiology PC
mi
from
Birmingham, AL
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
Cardiology PC
mi
from
Birmingham, AL
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
Arizona Heart Institute
mi
from
Phoenix, AZ
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
Arizona Heart Institute
mi
from
Phoenix, AZ
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
Mayo Clinic Hospital
mi
from
Phoenix, AZ
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
Mayo Clinic Hospital
mi
from
Phoenix, AZ
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
Scripps Green Hospital / Scripps Clinical Hospital
mi
from
La Jolla, CA
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
Scripps Green Hospital / Scripps Clinical Hospital
mi
from
La Jolla, CA
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
Stanford Hospitals and Clinics
mi
from
Stanford, CA
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
Stanford Hospitals and Clinics
mi
from
Stanford, CA
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
MedStar Washington Hospital Center
mi
from
Washington,
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
MedStar Washington Hospital Center
mi
from
Washington,
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
Holy Cross Hospital
mi
from
Ft. Lauderdale, FL
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
Holy Cross Hospital
mi
from
Ft. Lauderdale, FL
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
University of Florida
mi
from
Gainesville, FL
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
Shands Jacksonville Medical Center
mi
from
Jacksonville, FL
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
Shands Jacksonville Medical Center
mi
from
Jacksonville, FL
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
Florida Hospital
mi
from
Orlando, FL
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
Florida Hospital
mi
from
Orlando, FL
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
Saint Joseph's Research Institute
mi
from
Atlanta, GA
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
Saint Joseph's Research Institute
mi
from
Atlanta, GA
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
Northwestern Cardiovascular Institute
mi
from
Chicago, IL
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
Northwestern Cardiovascular Institute
mi
from
Chicago, IL
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
Rush University Medical Center
mi
from
Chicago, IL
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
University of Iowa Health Care
mi
from
Iowa City, IA
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
University of Iowa Health Care
mi
from
Iowa City, IA
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
Massachusetts General Hospital
mi
from
Boston, MA
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
Caritas Saint Elizabeth's Medical Center
mi
from
Boston, MA
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
Caritas Saint Elizabeth's Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
Minneapolis Heart Institute
mi
from
Minneapolis, MN
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
Minneapolis Heart Institute
mi
from
Minneapolis, MN
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
Weill-Cornell Medical College
mi
from
New York, NY
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
Weill-Cornell Medical College
mi
from
New York, NY
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
New York-Presbyterian Hospital
mi
from
New York, NY
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
New York-Presbyterian Hospital
mi
from
New York, NY
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
Lindner Clinical Trials Center
mi
from
Cincinnati, OH
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
Lindner Clinical Trials Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
University of Cincinnati Medical Center
mi
from
Cincinnati, OH
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
University of Cincinnati Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
University Hospitals of Cleveland
mi
from
Cleveland, OH
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
University Hospitals of Cleveland
mi
from
Cleveland, OH
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
Swedish Medical Center
mi
from
Seattle, WA
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
Swedish Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
University of Wisconsin
mi
from
Madison, WI
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
Heart Care Associates
mi
from
Milwaukee, WI
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
Heart Care Associates
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Low Dose One-Day Tc99m Protocol With a High-Efficiency Cardiac Dedicated Gamma Camera For Detection of Coronary Disease
Validation of a Low-Dose One-Day TC99m Protocol With a High-Efficiency Cardiac Dedicated Gamma Camera for Detection of Coronary Artery Disease
Status: Enrolling
Updated:  2/13/2011
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Low Dose One-Day Tc99m Protocol With a High-Efficiency Cardiac Dedicated Gamma Camera For Detection of Coronary Disease
Validation of a Low-Dose One-Day TC99m Protocol With a High-Efficiency Cardiac Dedicated Gamma Camera for Detection of Coronary Artery Disease
Status: Enrolling
Updated: 2/13/2011
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Low Dose One-Day Tc99m Protocol With a High-Efficiency Cardiac Dedicated Gamma Camera For Detection of Coronary Disease
Validation of a Low-Dose One-Day TC99m Protocol With a High-Efficiency Cardiac Dedicated Gamma Camera for Detection of Coronary Artery Disease
Status: Enrolling
Updated:  2/13/2011
Oregon Heart and Vascular Institute
mi
from
Springfield, OR
Low Dose One-Day Tc99m Protocol With a High-Efficiency Cardiac Dedicated Gamma Camera For Detection of Coronary Disease
Validation of a Low-Dose One-Day TC99m Protocol With a High-Efficiency Cardiac Dedicated Gamma Camera for Detection of Coronary Artery Disease
Status: Enrolling
Updated: 2/13/2011
Oregon Heart and Vascular Institute
mi
from
Springfield, OR
Click here to add this to my saved trials
Ranolazine, Ethnicity and the Metabolic Syndrome
Ranolazine, Ethnicity and the Metabolic Syndrome - REMS Study
Status: Enrolling
Updated:  2/24/2011
Atlanta Heart Specialist, LLC
mi
from
Cumming, GA
Ranolazine, Ethnicity and the Metabolic Syndrome
Ranolazine, Ethnicity and the Metabolic Syndrome - REMS Study
Status: Enrolling
Updated: 2/24/2011
Atlanta Heart Specialist, LLC
mi
from
Cumming, GA
Click here to add this to my saved trials
Ranolazine, Ethnicity and the Metabolic Syndrome
Ranolazine, Ethnicity and the Metabolic Syndrome - REMS Study
Status: Enrolling
Updated:  2/24/2011
Atlanta Heart Specialists, LLC
mi
from
Tucker, GA
Ranolazine, Ethnicity and the Metabolic Syndrome
Ranolazine, Ethnicity and the Metabolic Syndrome - REMS Study
Status: Enrolling
Updated: 2/24/2011
Atlanta Heart Specialists, LLC
mi
from
Tucker, GA
Click here to add this to my saved trials
Statin Therapy for Ischemic and Nonischemic Cardiomyopathy
Statin Induced Augmentation of Circulating Endothelial Progenitor Cells and Myocardial Viability in Patients With Ischemic and Nonischemic Cardiomyopathy
Status: Enrolling
Updated:  4/12/2011
Ohio State University
mi
from
Columbus, OH
Statin Therapy for Ischemic and Nonischemic Cardiomyopathy
Statin Induced Augmentation of Circulating Endothelial Progenitor Cells and Myocardial Viability in Patients With Ischemic and Nonischemic Cardiomyopathy
Status: Enrolling
Updated: 4/12/2011
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Multicenter Study to Rule Out Myocardial Infarction by Cardiac Computed Tomography
Rule Out Myocardial Ischemia/Infarction by Computer Assisted Tomography
Status: Enrolling
Updated:  5/16/2011
Massachusetts General Hospital
mi
from
Boston, MA
Multicenter Study to Rule Out Myocardial Infarction by Cardiac Computed Tomography
Rule Out Myocardial Ischemia/Infarction by Computer Assisted Tomography
Status: Enrolling
Updated: 5/16/2011
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Study Comparing CT Scan and Stress Test in Patients With Known Coronary Artery Disease Hospitalized for Chest Pain
A Randomized Controlled Trial Comparing Coronary CT Angiography and Radionuclide Stress Myocardial Perfusion Imaging in Symptomatic Inpatients With Known Coronary Artery Disease
Status: Enrolling
Updated:  6/27/2011
Montefiore Medical Center
mi
from
Bronx, NY
Study Comparing CT Scan and Stress Test in Patients With Known Coronary Artery Disease Hospitalized for Chest Pain
A Randomized Controlled Trial Comparing Coronary CT Angiography and Radionuclide Stress Myocardial Perfusion Imaging in Symptomatic Inpatients With Known Coronary Artery Disease
Status: Enrolling
Updated: 6/27/2011
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
T-Wave Alternans in Patients With Suspected Acute Coronary Syndrome
T-Wave Alternans in Patients Acute Coronary Syndrome
Status: Enrolling
Updated:  6/29/2011
Loma Linda University
mi
from
Loma Linda, CA
T-Wave Alternans in Patients With Suspected Acute Coronary Syndrome
T-Wave Alternans in Patients Acute Coronary Syndrome
Status: Enrolling
Updated: 6/29/2011
Loma Linda University
mi
from
Loma Linda, CA
Click here to add this to my saved trials
Acute Coronary Syndrome and Care-Seeking Delay: A Web Based Behavioral Study
Acute Coronary Syndrome and Care-Seeking Delay: A Web Based Behavioral Study
Status: Enrolling
Updated:  7/29/2011
Yale University School of Nursing
mi
from
New Haven, CT
Acute Coronary Syndrome and Care-Seeking Delay: A Web Based Behavioral Study
Acute Coronary Syndrome and Care-Seeking Delay: A Web Based Behavioral Study
Status: Enrolling
Updated: 7/29/2011
Yale University School of Nursing
mi
from
New Haven, CT
Click here to add this to my saved trials
Coronary Computed Tomography (CT) Angiography Versus Standard Therapy in the Emergency Room
64 Slice Coronary CT Angiography vs. Standard Therapy in the Emergency Room: Determining Cost-effectiveness and Predicting Clinical Outcome in Patients With Low and Moderate Risk for Acute Coronary Syndrome.
Status: Enrolling
Updated:  8/30/2011
University of Michigan Health System
mi
from
Ann Arbor, MI
Coronary Computed Tomography (CT) Angiography Versus Standard Therapy in the Emergency Room
64 Slice Coronary CT Angiography vs. Standard Therapy in the Emergency Room: Determining Cost-effectiveness and Predicting Clinical Outcome in Patients With Low and Moderate Risk for Acute Coronary Syndrome.
Status: Enrolling
Updated: 8/30/2011
University of Michigan Health System
mi
from
Ann Arbor, MI
Click here to add this to my saved trials